Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

NCT06263088 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT06263088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06263088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Lead sponsor
Case Comprehensive Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2024
Completion date
September 30, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, appendix cancer, colon cancer, esophageal cancer, gastrointestinal cancer, liver cancer, neuroendocrine tumors, pancreas cancer, rectal cancer, stomach cancer